ChromaDex (CDXC) Stock Highlights

3.55 | +4.11%

2024-09-19 05:04:53

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDexs patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagens website and through partnerships with retailers and distributors.

Statistics

Range Today

3.3 3.65

Volume Today 347.4K

Range 1 Year

1.25 4.65

Volume 1 Year 59.96M

Range 3 Year

1.15 6.98

Volume 3 Year 205.93M

Range 10 Year

1.15 23.66

Volume 10 Year 882.19M

Highlights

Market Capitalization 269.56M (small)

Floating Shares 48.94M

Current Price 3.55

Price To Earnings -116.67

Price To Revenue 2.87

Price To Book 8.74

Earnings Per Share -0.03

Payout Ratio 0%

Performance

Latest +4.11%

1 Month +5.97%

3 Months +21.16%

6 Months +44.9%

1 Year +143.15%

3 Years -45.22%

5 Years -15.88%

10 Years -1.39%

Benchmarks

Market Capitalization

248 / 368

Gross Profits

67 / 278

Total Revenue

96 / 300

Total Rank

86 / 368

Free Cashflow

31 / 352

Performance 5 years

150 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.